Elevated ubiquitination contributes to protective immunity against severe SARS‐CoV‐2 infection

Abstract

Background The crosstalk between the ubiquitin‐proteasome and the immune system plays an important role in the health and pathogenesis of viral infection. However, there have been few studies of ubiquitin activation in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Methods We investigated the effect of ubiquitination on SARS‐CoV‐2 infection and patient prognosis by integrating published coronavirus disease 2019 (COVID‐19) multi‐transcriptome data and bioinformatics methods. Results The differential expression of COVID‐19 samples revealed changed ubiquitination in most solid and hollow organs, and it was activated in lymphatic and other immune tissues. In addition, in the respiratory system of COVID‐19 patients, the immune response was mainly focused on the alveoli, and the expression of ubiquitination reflected increasing immune infiltration. Ubiquitination stratification could significantly differentiate patients' prognosis and inflammation levels through the general transcriptional analysis of the peripheral blood of patients with COVID‐19. Moreover, high ubiquitination levels were associated with a favourable prognosis, low inflammatory response, and reduced mechanical ventilation and intensive care unit. Moreover, high ubiquitination promoted a beneficial immune response while inhibiting immune damage. Finally, prognostic stratification and biomarker screening based on ubiquitination traits played an important role in clinical management and drug development. Conclusion Ubiquitination characteristics provides new ideas for clinical intervention and prognostic guidance for COVID‐19 patients.

Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration

“…The ubiquitination level in COVID-19 patients has been proposed as a potential prognostic indicator, as well as a promising target for therapeutic intervention [105]. In this study, Che et al (2022) utilized COVID-19 transcriptome data and bioinformatics to explore ubiquitination in COVID-19 patients.…”

Synthetic Methodologies and Therapeutic Potential of Indole-3-Carbinol (I3C) and Its Derivatives

“…In addition, they proved that I3C is able to block SARS-CoV-2 viral egression in the Vero E6 model through the inhibition of HECT proteins implicated in COVID-19 pathology. The importance of E3 ligases in the ubiquitination of some viral proteins has recently been confirmed by combined multi-omics studies that have allowed the demonstration of the ability of SARS-CoV-2 not only in the remodeling of innate immunity, but also in promoting viral infection, by hijacking specific processes of ubiquitination [ 138 ]. The role of ubiquitination processes in the survival of the virus have also been very recently confirmed by a study that demonstrated how ubiquitin variants are able to inhibit the production of new viral particles after infection, thus preventing the virus from spreading from one cell to another and wreaking havoc in the body [ 139 ].…”